← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Brookfield Wealth Solutions Ltd. (BNT) 10-Year Financial Performance & Capital Metrics

BNT • • Insurance & Managed Care
Financial ServicesDiversified InsuranceRetirement & Wealth SolutionsRetirement & Annuity Specialists
AboutBrookfield Reinsurance Ltd., through its subsidiaries, provides insurance and reinsurance services to individuals and institutions in the United States, Canada, and internationally. The company operates in three segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT). The Direct Insurance segment offers a range of insurance products and services including Whole, Universal, Variable Universal, and Credit Life insurance products; deferred, single premium immediate, and variable annuities; primary and excess casualty products, such as specialty casualty, construction defect, general liability, commercial multi-peril, workers compensation, product liability, environmental liability, and auto liability; professional liability including management, transaction, and errors and omissions liability; property insurance for homeowners and renters, inland marine, and auto physical damages; surety, animal mortality, and ocean marine insurance; and health insurance, credit insurance, and pension products. The Reinsurance segment provides reinsurance of annuity-based products, such as fixed, fixed index, and payout annuities. The PRT segment provides transfer by a corporate sponsor of the risks associated with the sponsorship and administration of a pension plan. The company was formerly known as Brookfield Asset Management Reinsurance Partners Ltd. and changed its name to Brookfield Reinsurance Ltd. in December 2022. Brookfield Reinsurance Ltd. was incorporated in 2020 and is headquartered in Pembroke, Bermuda.Show more
  • Revenue $14.34B +106.2%
  • Combined Ratio 91.54% +3.7%
  • Net Income $1.21B +52.5%
  • Return on Equity 11.07% -8.8%
  • Medical Cost Ratio 79.56% -5.7%
  • Operating Margin 8.46% -27.7%
  • Net Margin 8.47% -26.0%
  • ROA 1.2% -20.5%
  • Equity / Assets 9.34% -34.9%
  • Book Value per Share 75.99 +24.9%
  • Tangible BV/Share 61.62 +5.5%
  • Debt/Equity 0.35 -17.9%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Profitable underwriting: 91.5% combined ratio
  • ✓Strong 5Y profit CAGR of 189.2%
  • ✓Trading near 52-week high
  • ✓Trading at only 0.6x book value

✗Weaknesses

  • ✗Shares diluted 18.3% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y106.48%
3Y140.32%
TTM37.02%

Profit (Net Income) CAGR

10Y-
5Y189.21%
3Y-
TTM19.44%

EPS CAGR

10Y-
5Y100.06%
3Y-
TTM-17.5%

ROCE

10Y Avg0.63%
5Y Avg0.63%
3Y Avg1.59%
Latest1.2%

Peer Comparison

Retirement & Annuity Specialists
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
AEGAegon Ltd.11.66B7.7525.8350.4%4.24%13.27%6.1%0.54
PFGPrincipal Financial Group, Inc.19.82B90.2013.5018.02%7.53%9.61%22.88%0.36
EQHEquitable Holdings, Inc.13.68B47.7412.6318.13%-5.8%-35.73%10.86%1.90
SLFSun Life Financial Inc.34.63B62.5311.87-5.15%8.54%11.91%6.9%0.65
BNTBrookfield Wealth Solutions Ltd.2.88B48.036.81106.2%9.16%7.81%100%0.35

Profit & Loss

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Revenue+382M514M1.03B4.37B6.95B14.34B
Revenue Growth %-0.35%1.01%3.23%0.59%1.06%
Medical Costs & Claims+0506M1.12B3.73B5.87B11.41B
Medical Cost Ratio %------
Gross Profit+382M8M-85M635M1.08B2.93B
Gross Margin %------
Gross Profit Growth %--0.98%-11.63%8.47%0.71%1.7%
Operating Expenses+376M6M28M103M271M1.72B
OpEx / Revenue %------
Depreciation & Amortization217K0013M50M206M
Combined Ratio %------
Operating Income+6M2M-113M532M814M1.21B
Operating Margin %------
Operating Income Growth %--0.67%-57.5%5.71%0.53%0.49%
EBITDA+6.22M2M-112M545M864M1.42B
EBITDA Margin %------
Interest Expense001M104M249M362M
Non-Operating Income00-1M-104M-249M-362M
Pretax Income+6M2M-113M532M814M1.21B
Pretax Margin %------
Income Tax+01M-1M31M17M-34M
Effective Tax Rate %------
Net Income+6M1M-112M499M796M1.21B
Net Margin %------
Net Income Growth %--0.83%-113%5.46%0.6%0.53%
EPS (Diluted)+0.220.04-3.2513.755.477.05
EPS Growth %--0.84%-91.53%5.23%-0.6%0.29%
EPS (Basic)0.220.04-3.2513.755.477.05
Diluted Shares Outstanding27.82M27.82M34.45M30.92M145.47M172.08M

Balance Sheet

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Assets+926.71M1.44B11.49B43.46B61.64B139.95B
Asset Growth %-0.55%6.98%2.78%0.42%1.27%
Total Investment Assets+2.34M1.2B490M1.72B39.84B92.97B
Long-Term Investments2.34M1.19B490M1.72B25.55B62.06B
Short-Term Investments0001M21.89B16.76B
Total Current Assets+21.22M0403M2.83B00
Cash & Equivalents13.36M35M393M2.15B4.31B12.24B
Receivables1000K1000K1000K1000K1000K1000K
Other Current Assets0-39.87M00-27.31B-30.17B
Goodwill & Intangibles+003M173M356M2.47B
Goodwill000121M121M783M
Intangible Assets003M52M235M1.69B
PP&E (Net)316K2M2M194M294M272M
Other Assets902.83M-1.2B10.57B38.05B-26.2B-64.8B
Total Liabilities861.25M1.36B10.06B39.19B52.79B126.88B
Total Debt+198K1.25M693M3.8B3.74B4.54B
Net Debt-13.16M-33.75M300M1.66B-565M-7.7B
Long-Term Debt00693M3.8B2.47B3.54B
Short-Term Debt00001.28B1B
Total Current Liabilities+3.79M0214M2.07B00
Accounts Payable1.26M4M132M151M00
Deferred Revenue0082M78M00
Other Current Liabilities0-9.43M01.66B-1.84B-1.69B
Deferred Taxes000000
Other Liabilities857.27M-1.25M9.15B33.32B-2.47B-3.54B
Total Equity+65.46M83M1.44B4.26B8.85B13.08B
Equity Growth %-0.27%16.29%1.97%1.07%0.48%
Shareholders Equity65.46M83M1.44B4.26B8.7B12.23B
Minority Interest0008M146M850M
Retained Earnings38K1.65M0310M945M2.05B
Common Stock64.61M01.44B1.89B5.18B9.97B
Accumulated OCI806K3.54M0-523M-120M204M
Return on Equity (ROE)0.09%0.01%-0.15%0.18%0.12%0.11%
Return on Assets (ROA)0.01%0%-0.02%0.02%0.02%0.01%
Equity / Assets------
Debt / Equity0.00x0.02x0.48x0.89x0.42x0.35x
Book Value per Share2.352.9841.66137.9460.8375.99
Tangible BV per Share------

Cash Flow

Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+309M399M1.69B644M1.51B4.57B
Operating CF Growth %-0.29%3.23%-0.62%1.34%2.03%
Operating CF / Revenue %------
Net Income6M1M-112M501M797M1.25B
Depreciation & Amortization217K0013M50M206M
Stock-Based Compensation000000
Deferred Taxes01M-25M22M12M-150M
Other Non-Cash Items-36.22M-81M-108M-388M-915M-9M
Working Capital Changes339M478M1.93B496M1.56B3.27B
Cash from Investing+-268M-385M-3.97B-4.88B-1.81B1.43B
Capital Expenditures-35K-617K-1M-24M-135M-40M
Acquisitions000-4.34B-274M10.84B
Purchase of Investments-1.01B-975M-5.43B-19.35B-24.46B-35.37B
Sale/Maturity of Investments1000K1000K1000K1000K1000K1000K
Other Investing-11.96M26.62M-643M-1.93B-987M-4.63B
Cash from Financing+-35M13M2.64B5.99B2.46B1.92B
Dividends Paid00-7.93M-5.76M-5.09M0
Share Repurchases00-8M-6M-5M-14M
Stock Issued5M13M1.41B450M04M
Debt Issuance (Net)001000K1000K-1000K-1000K
Other Financing-40M07.93M501.76M2.65B2.06B
Net Change in Cash+5M22M358M1.75B2.16B7.93B
Exchange Rate Effect-1000K-1000K1000K-1000K01000K
Cash at Beginning8M13M35M393M2.15B4.31B
Cash at End13M35M393M2.15B4.31B12.24B
Free Cash Flow+309M398M1.69B620M1.37B4.53B
FCF Growth %-0.29%3.24%-0.63%1.21%2.3%
FCF Margin %------
FCF per Share11.1114.348.9720.059.4326.32

Key Ratios

Metric201920202021202220232024
Combined Ratio98.43%99.61%110.94%87.83%88.29%91.54%
Medical Cost Ratio0%98.44%108.23%85.47%84.4%79.56%
Return on Equity (ROE)9.17%1.35%-14.76%17.51%12.14%11.07%
Return on Assets (ROA)0.65%0.08%-1.73%1.82%1.51%1.2%
Equity / Assets7.06%5.76%12.49%9.81%14.36%9.34%
Book Value / Share2.352.9841.66137.9460.8375.99
Debt / Equity0.00x0.02x0.48x0.89x0.42x0.35x
Revenue Growth-34.55%100.97%323.04%59.11%106.2%

Frequently Asked Questions

Valuation & Price

Brookfield Wealth Solutions Ltd. (BNT) has a price-to-earnings (P/E) ratio of 6.8x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Brookfield Wealth Solutions Ltd. (BNT) grew revenue by 106.2% over the past year. This is strong growth.

Yes, Brookfield Wealth Solutions Ltd. (BNT) is profitable, generating $1.32B in net income for fiscal year 2024 (8.5% net margin).

Dividend & Returns

Brookfield Wealth Solutions Ltd. (BNT) has a return on equity (ROE) of 11.1%. This is reasonable for most industries.

Industry Metrics

Brookfield Wealth Solutions Ltd. (BNT) has a combined ratio of 91.5%. A ratio below 100% indicates underwriting profitability.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.